Genetics Generation Advancement vs Thermo Fisher Scientific: Fair Value & Quality
Both stocks run through our valuation models. Here is how Genetics Generation Advancement (4160) and Thermo Fisher Scientific (TMO) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Genetics Generation Advancement trades at TWD 40.40 versus a fair value of TWD 13.61 (-66%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Genetics Generation Advancement
4160.TWO · TWD · Consumer Staples
-66%
upside to fair value
overvalued
PriceTWD 40.40
Fair ValueTWD 13.61
Quality37/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$594
Fair Value$308
Quality63/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
As of Aug 11, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Genetics Generation Advancement trades at TWD 40.40 versus a fair value of TWD 13.61 (-66%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Thermo Fisher Scientific has the higher quality score (63/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.